Joe Betts-LaCroix, Retro Bio CEO
A new anti-aging biotech wants to add 10 years to your life. But who's funding it?
Another relatively mysterious anti-aging biotech has emerged and the details are once again slim. Retro Biosciences said it has reeled in an initial pool of $180 million, but the investors remain anonymous.
Those funds are expected to bankroll first proofs of concept and “operation of the company through the decade,” the Redwood City, CA biotech said late Tuesday night in a Twitter post and update on its website. The posts collectively alerted the world to Retro’s lofty mission: “add 10 years to healthy human lifespan.”
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters